Author

Friederike Linden

OpenAlex ID: A5079712594

BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study

2023 · Thorsten H. Ecke, Christina J. Meisl, et al. · Urologic Oncology Seminars and Original Investigations · 31

Trophoblast cell surface antigen‐2: a promising new biomarker and potential therapeutic target in penile squamous cell carcinoma

2024 · Richard Weiten, Enno Storz, et al. · British Journal of Urology · 15

Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment

2022 · Thorsten H. Ecke, Paula Carolin Voß, et al. · International Journal of Molecular Sciences · 13

Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to Cytology

2024 · Thorsten H. Ecke, Christina J. Meisl, et al. · Urology · 11

Prediction of response to neoadjuvant chemotherapy of patients with muscle invasive bladder cancer by molecular subtyping and antibody drug conjugate target gene quantitation: Preview of Bladder BRIDGister.

2023 · Ralph M. Wirtz, Paula Carolin Voss, et al. · Journal of Clinical Oncology · 2

Prediction of nonresponse and theranostic imaging in MIBC being resistant to NACT within the Bladder BRIDGister.

2023 · Lucas Kastner, Ralph M. Wirtz, et al. · Journal of Clinical Oncology · 1

Mp61-08 Trop-2—a Promising New Therapeutic Target in Penile Squamous Cell Carcinoma

2024 · Richard Weiten, Carolina Kessler, et al. · The Journal of Urology

Mp15-01 Novel Urine-based Biomarker to Distinguish Muscle-invasive From Non-muscle Invasive Bladder Cancer–a Multicentric Approach

2024 · Barbara Koeditz, Lucas Kastner, et al. · The Journal of Urology

Prediction of response to neoadjuvant chemotherapy of patients with muscle invasive bladder cancer by molecular subtyping and radioligand target quantitation: Preview of the Bladder BRIDGister.

2023 · Ralph M. Wirtz, Paula Carolin Voss, et al. · Journal of Clinical Oncology

Works count: 9

Citation count: 73

H-index: 4

I10-index: 4